Market Closed -
OTC Markets
12:52:15 11/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.2
USD
|
0.00%
|
|
-20.00%
|
+100.00%
|
Fiscal Period: July |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1.19
|
1,300
|
1,831
|
1,278
|
331.4
|
298.3
|
Enterprise Value (EV)
1 |
1.186
|
1,300
|
1,831
|
1,280
|
337.8
|
305
|
P/E ratio
|
-4.83
x
|
-71.9
x
|
-1,617
x
|
-248
x
|
-15.8
x
|
-28.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-1,87,99,973
x
|
-3,07,73,529
x
|
EV / FCF
|
1.1
x
|
339
x
|
-23,283
x
|
9,202
x
|
79.8
x
|
89.5
x
|
FCF Yield
|
91.2%
|
0.29%
|
-0%
|
0.01%
|
1.25%
|
1.12%
|
Price to Book
|
-15,385
x
|
-8,621
x
|
-4,363
x
|
-518
x
|
-46.3
x
|
-32
x
|
Nbr of stocks (in thousands)
|
595
|
2,88,938
|
3,00,114
|
3,00,683
|
3,01,283
|
3,01,303
|
Reference price
2 |
2.000
|
4.500
|
6.100
|
4.250
|
1.100
|
0.9900
|
Announcement Date
|
06/12/18
|
13/11/19
|
13/11/20
|
11/02/22
|
07/11/22
|
05/01/24
|
Fiscal Period: July |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-17.97
|
-9.912
|
EBIT
1 |
-3.803
|
-10.65
|
-1.09
|
-5.088
|
-18.04
|
-10.05
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-3.832
|
-10.65
|
-1.107
|
-5.156
|
-20.91
|
-10.31
|
Net income
1 |
-3.832
|
-10.65
|
-1.107
|
-5.156
|
-20.91
|
-10.31
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.4141
|
-0.0626
|
-0.003773
|
-0.0172
|
-0.0695
|
-0.0342
|
Free Cash Flow
1 |
1.082
|
3.834
|
-0.0786
|
0.1391
|
4.234
|
3.408
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/12/18
|
13/11/19
|
13/11/20
|
11/02/22
|
07/11/22
|
05/01/24
|
Fiscal Period: July |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
0.15
|
0.35
|
1.88
|
6.36
|
6.74
|
Net Cash position
1 |
0
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.3541
x
|
-0.6801
x
|
Free Cash Flow
1 |
1.08
|
3.83
|
-0.08
|
0.14
|
4.23
|
3.41
|
ROE (net income / shareholders' equity)
|
7,923%
|
13,275%
|
388%
|
357%
|
435%
|
125%
|
ROA (Net income/ Total Assets)
|
-35,913%
|
-90,142%
|
-6,370%
|
-9,538%
|
-3,015%
|
-1,071%
|
Assets
1 |
0.0107
|
0.0118
|
0.0174
|
0.0541
|
0.6937
|
0.9619
|
Book Value Per Share
2 |
-0
|
-0
|
-0
|
-0.0100
|
-0.0200
|
-0.0300
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/12/18
|
13/11/19
|
13/11/20
|
11/02/22
|
07/11/22
|
05/01/24
|
|
1st Jan change
|
Capi.
|
---|
| +100.00% | 60.26M | | -.--% | 339M | | +34.02% | 277M | | +33.33% | 261M | | +39.53% | 182M | | +156.53% | 150M | | -33.33% | 137M | | +50.41% | 136M | | -28.57% | 121M | | -7.69% | 80.3M |
Medical Farming
|